Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on July 22, 2004

Stroke. 2004
Published online before print July 22, 2004, doi: 10.1161/01.STR.0000138450.15078.b5
A more recent version of this article appeared on September 1, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/9/2099    most recent
01.STR.0000138450.15078.b5v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fiehler, J.
Right arrow Articles by Zeumer, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fiehler, J.
Right arrow Articles by Zeumer, H.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*MRI Scans
*Stroke
Related Collections
Right arrow Fibrinolysis
Right arrow CT and MRI
Right arrow Acute Cerebral Infarction
Right arrow Emergency treatment of Stroke
Right arrow Computerized tomography and Magnetic Resonance Imaging
Right arrow Thrombolysis

Submitted on February 19, 2004
Revised on May 20, 2004
Accepted on June 21, 2004

Are There Time-Dependent Differences in Diffusion and Perfusion Within the First 6 Hours After Stroke Onset?

Jens Fiehler MD*; Thomas Kucinski MD; Karina Knudsen MSt; Michael Rosenkranz MD; Götz Thomalla MD; Cornelius Weiller MD; Joachim Röther MD; and Hermann Zeumer MD

From the Departments of Neuroradiology (J.F., T.K., K.K., H.Z.) and Neurology (M.R., G.T., C.W., J.R.), University Hospital Eppendorf, University of Hamburg, Germany.

* To whom correspondence should be addressed. E-mail: fiehler{at}uke.uni-hamburg.de.

Background and Purpose--Stroke heterogeneity in computed tomography-based studies has been attributed as main cause for missing efficacy of intravenous tissue plasminogen activator (tPA) therapy within 3 to 6 hours. We investigated early time-dependent differences in acute stroke pathophysiology by multiparametric magnetic resonance imaging (MRI).

Methods--Stroke MRI of 112 acute ischemic stroke patients within <6 hours were dichotomized into a <3-hour group (n=52) and a 3- to 6-hour group (n=60). Infarct volume was determined on days 5 to 8. Lesion volumes were determined for apparent diffusion coefficient (ADC_man) and the subregion with ADC values <550x10-9 mm/s2 (ADC <550), and for the time-to-peak (TTP) delay of 2 to 4 seconds, 4 to 6 seconds, 6 to 8 seconds, and >8 seconds. A subsample analysis was performed for occlusions of the middle carotid artery (MCA) trunk (n=36) and MCA branches (n=30), and for all patients treated by intravenous tPA (n=70).

Results--ADC and TTP lesion volumes were not different within <3 hours compared with volumes at 3 to 6 hours. In patients receiving intravenous tPA (n=70), there were no significant differences in ADC_man, TTP >2 seconds, and infarct volume (days 5 to 8) between the 2 groups. There was a greater proportion of ADC <550/ADC_man, which was most pronounced in patients with MCA trunk occlusions after 3 to 6 hours and a larger mismatch in the <3-hour group compared with that of the 3- to 6-hour group. In MCA branch occlusions, there was a less severe TTP delay after 3 to 6 hours. However, all differences missed the significance level (P=0.05) after correction for multiple testing.

Conclusions--We observed no significant time-dependent differences within 6 hours after stroke onset in degree and volume of diffusion and perfusion impairment. An exclusion from intravenous tPA solely based on a rigid 3-hour time window seems unjustified in MRI-confirmed ischemic stroke.


Key words: ischemia • magnetic resonance imaging • magnetic resonance imaging, diffusion-weighted • stroke, acute • thrombolysis




This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
P.G. Kranz and J.D. Eastwood
Does Diffusion-Weighted Imaging Represent the Ischemic Core? An Evidence-Based Systematic Review
AJNR Am. J. Neuroradiol., June 1, 2009; 30(6): 1206 - 1212.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. Sasaki, K. Yamada, Y. Watanabe, M. Matsui, M. Ida, S. Fujiwara, and E. Shibata
Variability in Absolute Apparent Diffusion Coefficient Values across Different Platforms May Be Substantial: A Multivendor, Multi-institutional Comparison Study
Radiology, November 1, 2008; 249(2): 624 - 630.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. Thomalla, A. Kruetzelmann, S. Siemonsen, C. Gerloff, M. Rosenkranz, J. Rother, and J. Fiehler
Clinical and Tissue Response to Intravenous Thrombolysis in Tandem Internal Carotid Artery/Middle Cerebral Artery Occlusion: An MRI Study
Stroke, May 1, 2008; 39(5): 1616 - 1618.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
C. Oppenheim, C. Lamy, E. Touze, D. Calvet, M. Hamon, J.-L. Mas, and J.-F. Meder
Do transient ischemic attacks with diffusion-weighted imaging abnormalities correspond to brain infarctions?
AJNR Am. J. Neuroradiol., September 1, 2006; 27(8): 1782 - 1787.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
O. Wu, S. Christensen, N. Hjort, R. M. Dijkhuizen, T. Kucinski, J. Fiehler, G. Thomalla, J. Rother, and L. Ostergaard
Characterizing physiological heterogeneity of infarction risk in acute human ischaemic stroke using MRI
Brain, September 1, 2006; 129(9): 2384 - 2393.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. Thomalla, C. Schwark, J. Sobesky, E. Bluhmki, J. B. Fiebach, J. Fiehler, O. Zaro Weber, T. Kucinski, E. Juettler, P. A. Ringleb, et al.
Outcome and Symptomatic Bleeding Complications of Intravenous Thrombolysis Within 6 Hours in MRI-Selected Stroke Patients: Comparison of a German Multicenter Study With the Pooled Data of ATLANTIS, ECASS, and NINDS tPA Trials
Stroke, March 1, 2006; 37(3): 852 - 858.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D.-W. Kang, J. A. Chalela, W. Dunn, S. Warach, and NIH-Suburban Stroke Center Investigators
MRI Screening Before Standard Tissue Plasminogen Activator Therapy Is Feasible and Safe
Stroke, September 1, 2005; 36(9): 1939 - 1943.
[Abstract] [Full Text] [PDF]